Combination drug therapy

Journal of the American Medical Directors Association

Volumn 6, Issue 6, 2005, Pages 406-409

  Tangalos, Eric G ^a   Zarowitz, Barbara J ^b,c  

^a MAYO CLINIC   (United States)

^b Omnicare Inc   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; AMLODIPINE; AMLODIPINE PLUS ATORVASTATIN; ATORVASTATIN; CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; DEXTROPROPOXYPHENE; ENTACAPONE; EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; FLUTICASONE PROPIONATE PLUS SALMETEROL; GLIBENCLAMIDE PLUS METFORMIN; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; INSULIN ASPART; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; ISOPHANE INSULIN; LOSARTAN; LOSARTAN POTASSIUM; LOVASTATIN PLUS NICOTINIC ACID; METFORMIN; METFORMIN PLUS ROSIGLITAZONE; MEVINOLIN; NICOTINIC ACID; PARACETAMOL; PARACETAMOL PLUS TRAMADOL; ROSIGLITAZONE; SIMVASTATIN; TRAMADOL; VALSARTAN;

AGING; ASTHMA; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; DIZZINESS; DRUG ABSORPTION; DRUG COST; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG RESEARCH; DRUG SAFETY; FALLING; GLUCURONIDATION; HUMAN; HYPERLIPIDEMIA; MEDICAID; PAIN; PARKINSON DISEASE; PATIENT COMPLIANCE; POLYPHARMACY; PRACTICE GUIDELINE; REVIEW; SIDE EFFECT; STROKE;

EID: 28744456436     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2005.04.013     Document Type: Article

References (27)

1. T. Higashi, P.G. Shekelle, D.H. Solomon The quality of pharmacologic care for vulnerable older patients Ann Intern Med 140 2004 714 720
2. US Food and Drug Administration, Center for New Drug Evaluation and Research. CDER drug and biologic approvals for calendar year 2004. Available at: http://www.fda.gov/cder/rdmt/ndaaps04cy.htm. Accessed February 16, 2005.
3. K. Turnheim Drug dosage in the elderly Is it rational? Drugs and Aging 13 1998 357 359
4. C. Herlinger, U. Klotz Drug metabolism and drug interactions in the elderly Best Pract Res Clin Gastroenterol 15 2001 897 918
5. Center for Medicaid and State Operations/Survey and Certification Group. Centers for Medicare and Medicaid Services. Department of Health and Human Services. Interpretive guidelines: Unnecessary Medications. Available at: http://www.ascp.com/public/ga/nfsurvey/changes04. Accessed February 16, 2005.
6. D.M. Fick, J.W. Cooper, W.E. Wade Updating the Beers criteria for potentially inappropriate medication use in older adults. Results of a US consensus panel of experts Arch Intern Med 163 2003 2716 2724
7. M. Perri, A.M. Menon, A.D. Deshpande Adverse outcomes associated with inappropriate drug use in nursing homes Ann Pharmacother 39 2005 405 411
8. C. Shanley, G. O'Loughlin Dysphagia among nursing home residents An assessment and management protocol J Gerontol Nurs 26 2000 35 48
9. J.H. Gurwitz Polypharmacy A new paradigm for quality drug therapy in the elderly? Arch Intern Med 164 2004 1957 1958
10. The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC 7) Arch Intern Med 289 2003 2560 2572
11. American Diabetes Association (ADA). Management of dyslipidemia in adults with diabetes Diabetes Care 27 Suppl 1 2004 S67 S71
12. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III) JAMA 285 2001 2486 2497
13. Executive summary of the National Asthma Education and Prevention Program (NAEPP) of the National Heart, Lung and Blood Institute. Guidelines for the diagnosis and management of asthma - update on selected topics 2002. Available at: http://www/nhlbi.nih.gov. Accessed February 16, 2005.
14. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 S172 S696
15. K. Schroeder, T. Fahey, S. Ebrahim How can we improve adherence to blood pressure-lowering medication in ambulatory care? Arch Intern Med 164; 2004 722 732
16. A. Richter, S.E. Anton, P. Koch, S.L. Dennett The impact of reducing dose frequency on health outcomes Clinical Ther 25 2003 2307 2335
17. P.T. Donnan, T.M. MacDonald, A.D. Morris Adherence to prescribed oral hypoglycemic medication in a population of patients with Type 2 diabetes A retrospective cohort study Diabetic Med 19 2002 279 284
18. M. Iskedjian, T.R. Einarson, L.D. MacKeigan Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy Evidence from a meta-analysis Clin Ther 24 2002 302 316
19. B. Waeber, H.R. Brunner Combination antihypertensive therapy Does it have a role in rational therapy? Am J Hypertens 10 1997 131S 137S
20. M. Epstein, G. Bakris Newer approaches to antihypertensive therapy Use of fixed-dose combination therapy Arch Intern Med 156 1996 1969 1978
21. A.A. Taylor, O. Shoheiber Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy Congest Heart Fail 9 2003 324 332
22. S.W. Stoloff, D.A. Stempel, J. Meyer Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies J Allergy Clin Immunol 113 2004 245 251
23. E. Chrischilles, D. Gilden, J. Kubisiak Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease Effectiveness of a two-in-one inhaler versus separate inhalers Am J Man Care 8 2002 901 911
24. A. Gulias-Herrero, C.A. Aguilar-Salinas, F.J. Gomez-Perez, J.A. Rull The combination metformin/glyburide exerts its hypoglycemic effect mainly by increasing insulin secretion A controlled, randomized, double-blind, crossover study Diabetes Nutr Metab 16 2003 268 276
25. L. Blonde, J. Wogen, C. Kreilick, A.A. Seymour Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin Diabetes Obes Metab 5 2003 424 431
26. Depression The Omnicare Formulary. Geriatric pharmaceutical care guidelines 2005 edition 2005 Omnicare, Inc Covington, KY 141 179
27. The Geriatric Pharmaceutical Care Guidelines 2005 Omnicare Inc, Covington, KY